Insight Molecular Diagnostics Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Insight Molecular Diagnostics Inc. (IMDX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $486.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-04-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-04-28
- Insight Molecular Diagnostics Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $486.00K.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$108.00K, a 138.30% decline year-over-year.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$9.00K, a 120.45% decline year-over-year.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$49.00K.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$181.00K, a 157.46% decline from fiscal 2015.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $315.00K, a 76.14% decline from fiscal 2014.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $1.32M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | $486.00K 10-Q · filed 2017-04-28 | $378.00K derived: sum of 2 quarters · filed 2017-04-28 | $369.00K derived: sum of 3 quarters · filed 2017-04-28 | $320.00K derived: sum of 4 quarters · filed 2017-04-28 |
| 2016-12-31 | -$108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$117.00K derived: sum of 2 quarters · filed 2017-02-27 | -$166.00K derived: sum of 3 quarters · filed 2017-02-27 | -$181.00K 10-K · filed 2017-02-27 |
| 2016-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$58.00K derived: sum of 2 quarters · filed 2016-11-10 | -$73.00K 10-Q · filed 2016-11-10 | $209.00K derived: sum of 4 quarters · filed 2017-04-28 |
| 2016-06-30 | -$49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$64.00K 10-Q · filed 2016-08-11 | $218.00K derived: sum of 3 quarters · filed 2017-04-28 | $262.00K derived: sum of 4 quarters · filed 2017-04-28 |
| 2016-03-31 | -$15.00K 10-Q · filed 2017-04-28 | $267.00K derived: sum of 2 quarters · filed 2017-04-28 | $311.00K derived: sum of 3 quarters · filed 2017-04-28 | $311.00K derived: sum of 4 quarters · filed 2017-04-28 |
| 2015-12-31 | $282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $326.00K derived: sum of 2 quarters · filed 2017-02-27 | $326.00K derived: sum of 3 quarters · filed 2017-02-27 | $315.00K 10-K · filed 2017-02-27 |
| 2015-09-30 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $44.00K derived: sum of 2 quarters · filed 2016-11-10 | $33.00K 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$11.00K 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | -$11.00K 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | $1.32M 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |